American Cyanamid Company

Bausch-lomb Incorporated

Leon Ellenbogen

Constance Anne Kohler

Stephen Paul Bartels

Frederick L Ferris, Iii

Jin Kinoshita

Cara Larraine Baustian

James Cecil Smith, Jr

George Edwin Bunce

David A Souerwine

Lisa C Buono

A daily nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The ingredients of the daily nutritional or dietary supplement composition include vitamin C, vitamin E, lutein, zinc and copper. The ingredients are preferably provided in a tablet form suitable for oral ingestion.

Nutritional supplement to treat macular degeneration

A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.

A dietary supplement composition is disclosed which comprises a calcium salt, vitamin D and at least one mineral, preferably a boron compound. Other minerals may be present, in addition to, or instead of the boron compound, such as copper compounds, Magnesium compounds, manganese compounds and zinc compounds.

Calcium dietary supplement

Multimineral dietary supplement compositions of enhanced iron bioavailability are provided by the use of controlled quantities of oxides and carbonates of calcium and magnesium.

Prenatal iron supplements

The use of 3-(4-biphenylcarbonyl)propionic acid in the treatment of blood platelet aggregation.

3-(4-Biphenylcarbonyl)propionic acid as an inhibitor of platelet

The use of 4-biphenylacetic acid in the amelioration of blood platelet aggregation.

Growing community of inventors

New City, NY, United States of America

Leon Ellenbogen